• Most Popular
  • Most Shared

UPDATE 1-Daiichi Sankyo begins late-stage trials of flu drug

Thu Nov 5, 2009 12:28am EST

Stocks

   

* Seeks to apply for approval by March 2010

Japan  |  Healthcare

* Shares down 2.8 percent vs 1.1 pct decline for Nikkei

TOKYO, Nov 5 (Reuters) - Daiichi Sankyo (4568.T), Japan's third-largest drugmaker, said on Thursday it has begun a late-stage trial in Japan for the influenza treatment laninamivir, a drug that aims to prevent new H1N1 flu as well as bird flu infections.

Daiichi Sankyo plans to apply for approval of the drug, which is also known as CS-8958 and which is taken by inhalation, by March 2010. It aims to bring it to market by March 2011.

Australian drugmaker Biota (BTA.AX) owns the U.S. and UK rights to develop and market the drug.

Japan's Shionogi (4507.T) said this week it has applied for approval of the experimental influenza treatment peramivir, an intravenous drug, in Japan. [ID:nTFA006488]

It bought the Japan and Taiwan rights to peramivir from U.S. firm BioCryst (BCRX.O). Peramivir recently gained U.S. approval approval for emergency use to patients who are severely ill in hospital. [ID:nN21505080]

Shares of Daiichi Sankyo lost 2.8 percent to 1,746 yen, underperforming a 1.1 percent decline for the benchmark Nikkei average .N225. (Reporting by Yumiko Nishitani; Editing by Edwina Gibbs)

Japan
Healthcare


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets